487 results on '"Van Laethem, J."'
Search Results
2. Infecties van het centrale zenuwstelsel
3. Correction to: Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers
4. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer
5. Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers
6. Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced/metastatic biliary tumors: REACHIN, a randomized, double-blind, phase II trial
7. Reliability and validity of the Dutch version of the Parents’ Postoperative Pain Measure (PPPM-Dv)
8. Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients
9. PO-1380 Evaluation of loco-regional recurrences using DIR after iHD-SBRT in localised pancreatic cancer
10. PO-1378 Isotoxic high-dose SBRT versus CRT for localized pancreatic cancer : a single center evaluation
11. The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona
12. EUS-guided radiofrequency ablation versus surgical resection for treatment of pancreatic insulinoma: a multicenter propensity score-matched study
13. The need for biliary drainage and its impact on the oncological management of patients with newly diagnosed biliary tract tumors
14. PC.01.6 ENDOSCOPIC ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION VERSUS SURGICAL RESECTION FOR TREATMENT OF PANCREATIC INSULINOMA: A MULTICENTER PROPENSITY SCOREMATCHED STUDY
15. A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial
16. Isotoxic high-dose stereotactic body radiotherapy (iHD-SBRT) for the treatment of non-metastastic pancreatic ductal adenocarcinoma and the randomised phase II STEREOPAC trial
17. Neoadjuvant Chemotherapy with Isotoxic High-dose SBRT Does Not Increase Postoperative Complications after Pancreatoduodenectomy for Non-metastatic Pancreatic Cancer
18. 321P A comprehensive predicting model of recurrence in stage III colon cancer from PETACC-8 trial
19. How to identify older patients with cancer who should benefit from comprehensive geriatric assessment?
20. New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel
21. FEATURES OF POST-OBSTRUCTIVE PNEUMONIA IN ADVANCED LUNG CANCER PATIENTS: A LARGE RETROSPECTIVE COHORT
22. Management of Malignant Biliary Strictures
23. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
24. LARGE SUPERFICIAL SQUAMOUS CELL CARCINOMA IN THE SETTING OF ACHALASIA TREATED BY ENDOSCOPIC SUBMUCOSAL DISSECTION: PARTICULAR FEATURES OF SUPERFICIAL CARCINOMA ON STASIS RELATED ESOPHAGEAL HYPERKERATOSIS
25. Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas†
26. Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I–II study
27. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
28. Troponin T in COVID-19 hospitalized patients: kinetics matter
29. Anticipating pancreatic cancer diagnosis through early computerised tomography findings: An ongoing holy quest
30. L’espace enfants/adolescents, un lieu d’accueil pour les enfants et les adolescents dont un parent est atteint d’un cancer
31. KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
32. Pathological complete response after neoadjuvant immunotherapy for a patient with microsatellite instability locally advanced rectal cancer: should we adapt our standard management for these patients?
33. Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset
34. Effect of hospital volume on quality of care and outcome after rectal cancer surgery
35. The management of locally advanced pancreatic cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona
36. P-276 Sex and regorafenib toxicity in refractory colorectal cancer: A safety analysis of the RegARd-C trial
37. Antibiotic prescriptions in the context of suspected bacterial respiratory tract superinfections in the COVID-19 era: a retrospective quantitative analysis of antibiotic consumption and identification of antibiotic prescription drivers
38. 599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)
39. Pristine Visibility Associated to the use of Texture and Colour Enhancement Imaging (TXI) During Submucosal Dissection: A Case of Large Barrett’s Neoplasia
40. The management of metastatic pancreatic cancer: expert discussion and recommendations from the 14th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2012
41. Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma
42. Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study
43. Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study
44. PD-0420: Induction by mFOLFIRINOX followed by SIBSBRT for the neoadjuvant treatment of pancreatic cancer.
45. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib
46. Fatal hemobilia in advanced hepatocellular carcinoma invading biliary tract after treatment with sorafenib and biliary stenting
47. Efficacy and safety of sorafenib in patients with advanced HCC and prior anti-tumor therapy: a subanalysis from the SHARP trial: PO596
48. The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006
49. A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
50. Irinotecan in combination with new agents
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.